The American College of Gastroenterology Irritable Bowel Syndrome Monograph: Translating Systematic Review Data to Clinical Practice

Gastroenterology

Volumn 138, Issue 2, 2010, Pages 789-791

  Moayyedi, Paul ^a   Ford, Alexander C ^b   Quigley, Eamonn M M ^c   Foxx Orenstein, Amy E ^d   Chey, William D ^e   Talley, Nicholas J ^d   Brandt, Lawrence J ^f  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIDEPRESSANT AGENT; PEPPERMINT OIL; TEGASEROD;

CLINICAL PRACTICE; CLINICAL TRIAL; EVIDENCE BASED PRACTICE; HUMAN; IRRITABLE COLON; LETTER; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 75149120507     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.09.077     Document Type: Letter

References (10)

1. Camilleri M., and Mayer E.A. Developing irritable bowel syndrome guidelines through meta-analysis: has the emperor really got new clothes?. Gastroenterology 137 (2009) 766-769
2. American College of Gastroenterology IBS Task Force. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 104 Suppl 1 (2009) S1-S35
3. Moayyedi P. Evidence-based medicine-the emperor's new clothes?. Am J Gastroenterol 103 (2008) 2967-2969
4. In: Higgins J.P.T., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions Version 5.0.1 [updated September 2008] (2008), The Cochrane Collaboration. www.cochrane-handbook.org Accessed August 31, 2009
5. Ford A.C., Talley N.J., Spiegel B.M.R., et al. Efficacy of fibre, antispasmodics, and peppermint oil in irritable bowel syndrome: systematic review and meta-analysis. Br Med J 337 (2008) 1388-1392
6. Bijkerk C.J., de Wit N.J., Muris J.W.M., et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care?. Randomised placebo controlled trial. BMJ 339 (2009) b3154
7. Quartero A.O., Meineche-Schmidt V., Muris J., et al. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2 (2005) CD003460
8. Ford A.C., Talley N.J., Schoenfeld P.S., et al. Efficacy of antidepressants in irritable bowel syndrome: systematic review and meta-analysis. Gut 58 (2009) 367-378
9. Ford A.C., Guyatt G.H., Talley N.J., et al. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol (2009 Nov 17) [Epub ahead of print]
10. Ford A.C., Brandt L.J., Young C., et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 104 (2009) 1831-1843